Literature DB >> 12373263

Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects.

Kazuhisa Asai1, Hiroshi Kanazawa, Kenichiro Otani, Satoshi Shiraishi, Kazuto Hirata, Junichi Yoshikawa.   

Abstract

BACKGROUND: Angiogenesis has recently attracted considerable attention as a component of airway remodeling in bronchial asthma. Vascular endothelial growth factor (VEGF) is highly expressed in asthmatic airways, and its contribution to airway remodeling has been reported. Although angiogenesis is regulated by a balance of angiogenic and antiangiogenic factors, the relative levels of antiangiogenic factors in asthmatic airways have not been evaluated.
OBJECTIVE: We sought to determine whether an imbalance between angiogenic and antiangiogenic factors exists in asthmatic airways.
METHODS: We simultaneously measured VEGF and endostatin levels and evaluated their correlation and balance in induced sputum from 18 steroid-naive asthmatic subjects and 11 healthy control subjects. After initial sputum induction, asthmatic subjects underwent 8 weeks of inhaled beclomethasone dipropionate (BDP; 800 microg/d) therapy, and sputum induction was then repeated.
RESULTS: VEGF and endostatin levels in induced sputum were significantly higher in asthmatic subjects than in control subjects (P <.001). There was a significant correlation between VEGF and endostatin levels in both control subjects (r = 0.995, P <.001) and asthmatic subjects (r = 0.923, P <.001). Moreover, the VEGF/endostatin level ratio in asthmatic subjects was significantly higher than that in control subjects (P <.0001). After 8 weeks of inhaled BDP therapy, the VEGF level in induced sputum in asthmatic subjects was significantly decreased (P <.001), whereas the endostatin level was not. A correlation between VEGF and endostatin levels existed even after BDP therapy (r = 0.861, P <.001). Moreover, the VEGF/endostatin level ratio was significantly decreased to the same level as in the control subjects after BDP therapy (P <.0001).
CONCLUSION: There was an imbalance between VEGF and endostatin levels in induced sputum from asthmatic subjects. This imbalance might play an important role in the pathogenesis of bronchial asthma through its effects on angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12373263     DOI: 10.1067/mai.2002.127797

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  29 in total

1.  Effect of combined hormonal and insulin therapy on the steroid hormone receptors and growth factors signalling in diabetic mice prostate.

Authors:  Wagner J Fávaro; Valéria H A Cagnon
Journal:  Int J Exp Pathol       Date:  2010-10-05       Impact factor: 1.925

2.  Functional variants of the sphingosine-1-phosphate receptor 1 gene associate with asthma susceptibility.

Authors:  Xiaoguang Sun; Shwu-Fan Ma; Michael S Wade; Carlos Flores; Maria Pino-Yanes; Jaideep Moitra; Carole Ober; Rick Kittles; Aliya N Husain; Jean G Ford; Joe G N Garcia
Journal:  J Allergy Clin Immunol       Date:  2010-07-10       Impact factor: 10.793

3.  Inhibition of p38 MAPK reduces expression of vascular endothelial growth factor in allergic airway disease.

Authors:  So Ri Kim; Kyung Sun Lee; Seoung Ju Park; Myung Shin Jeon; Yong Chul Lee
Journal:  J Clin Immunol       Date:  2012-02-24       Impact factor: 8.317

Review 4.  Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease.

Authors:  Chun Geun Lee; Bing Ma; Seyedtaghi Takyar; Farida Ahangari; Charles Delacruz; Chuan Hua He; Jack A Elias
Journal:  Proc Am Thorac Soc       Date:  2011-11

5.  Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung.

Authors:  Vineet Bhandari; Rayman Choo-Wing; Svetlana P Chapoval; Chun G Lee; C Tang; Y K Kim; Bing Ma; Peter Baluk; Michelle I Lin; Donald M McDonald; Robert J Homer; William C Sessa; Jack A Elias
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

Review 6.  Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma.

Authors:  Hyun Lee; So Ri Kim; Youngman Oh; Seong Ho Cho; Robert P Schleimer; Yong Chul Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

7.  Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis.

Authors:  Hyun Sil Lee; Allen Myers; Jean Kim
Journal:  Am J Respir Crit Care Med       Date:  2009-09-17       Impact factor: 21.405

Review 8.  Angioplasticity in asthma.

Authors:  Kewal Asosingh; Serpil C Erzurum
Journal:  Biochem Soc Trans       Date:  2009-08       Impact factor: 5.407

9.  A pooling-based genome-wide analysis identifies new potential candidate genes for atopy in the European Community Respiratory Health Survey (ECRHS).

Authors:  Francesc Castro-Giner; Mariona Bustamante; Juan Ramon González; Manolis Kogevinas; Deborah Jarvis; Joachim Heinrich; Josep-Maria Antó; Matthias Wjst; Xavier Estivill; Rafael de Cid
Journal:  BMC Med Genet       Date:  2009-12-06       Impact factor: 2.103

10.  Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients.

Authors:  Jeong-Hee Choi; Yu-Jin Suh; Soo-Keol Lee; Chang-Hee Suh; Dong-Ho Nahm; Hae-Sim Park
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.